A respiratory device that Baxter inherited through its $12.5 billion Hillrom acquisition might work a little too well, a problem that prompted the company to issue an urgent medical device correction.
A device that’s meant to clear out and expand the lungs may actually go too far, resulting in a potentially dangerous decrease in overall oxygen levels, Baxter said this week. In light of that ...
CHICAGO, July 13, 2020 /PRNewswire/ -- Global medical technology leader Hillrom (NYSE: HRC) today announced the launch of two new respiratory therapy devices: the Volara™ System, which provides ...
Breathing devices, including inhalers, nebulizers, and larger devices, can help improve your breathing with COPD. Which device a doctor recommends can depend on your symptoms. If you’re living with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback